U.S. Attorney for the District of Columbia Jeanine Pirro spent the week defending her office’s criminal investigation into ...

The average one-year price target for Vor Biopharma (NasdaqGS:VOR) has been revised to $37.13 / share. This is a decrease of ...

In February, after 53 years, humans could launch to the moon again for the first time. NASA is now beginning the final ...

Fintel reports that on January 9, 2026, Citigroup initiated coverage of Vor Biopharma (NasdaqGS:VOR) with a Buy ...

Kupfer hat seine beeindruckende Rally fortgesetzt, nachdem das Industriemetall erstmals die Preismarke von 13.000 Dollar pro Tonne überschritten hat. Investoren positionieren sich zunehmend für ein ...

Vor Biopharma Inc. (VOR) stock jumped to a high of $12 yesterday, gaining >20%, but as I discovered to my detriment recently, all is not exactly what it seems at the company. In this post I revisit a ...

Investing.com - JPMorgan initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a $43.00 price target, citing the potential of its telitacicept drug. The target ...

Fintel reports that on December 17, 2025, TD Cowen initiated coverage of Vor Biopharma (NasdaqGS:VOR) with a Buy recommendation. As of December 6, 2025, the average one-year price target for Vor ...

Vor Biopharma's estimated fair value is US$15.10 based on 2 Stage Free Cash Flow to Equity Vor Biopharma is estimated to be 49% undervalued based on current share price of US$7.68 Our fair value ...

While the Switch 2 itself isn't on sale, you can still find good prices on bundles and accessories. The Switch 2 console itself is at its typical price ($449) at most retailers, including Amazon and ...

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today reported financial results for the ...

Vor Biopharma shares fell sharply Tuesday in premarket trading after the company priced its $100 million offering below recent trading prices. Shares traded 31% lower ahead of the morning bell at ...